QLH12016 + Enzalutamide + ABIRATERONE ACETATE for prostatic neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 5 Aug 2025: Trial registered, NCT07104110

The trials

NCT07104110: Study of QLH12016 in Combination With Novel Hormonal Agent in Subjects With Advanced Prostate Cancer

State
Not started
Phase
Phase 1 and Phase 2
People
50 planned
Started
Oct 2025
Primary completion
Oct 2027
Arms
QLH12016+NHA
Results
None posted
  1. 5 Aug 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.